INDSWIFT LABORATORIES
Back to Income Statement
|
INDSWIFT LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹421 Cr | ₹48 Cr | ₹-2.15 Cr | ₹-3.15 Cr | ₹-21 Cr |
What is the latest Consolidated Net Profit of INDSWIFT LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹421 Cr |
| Mar2024 | ₹48 Cr |
| Mar2023 | ₹-2.15 Cr |
| Mar2022 | ₹-3.15 Cr |
| Mar2021 | ₹-21 Cr |
How is Consolidated Net Profit of INDSWIFT LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹421 Cr | 784.43 | |
| Mar2024 | ₹48 Cr | Positive | |
| Mar2023 | ₹-2.15 Cr | Negative | |
| Mar2022 | ₹-3.15 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Consolidated Net Profit of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,143.7 Cr | 11.1% | 51.4% | 105.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 11.1% |
51.4% |
105.2% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses